The U.S. Varicose Vein Treatment Devices Market size is expected to reach USD 795.1 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as obesity, pregnancy, sedentary lifestyle, and physical activities like standing for longer durations is expected to drive the market growth.
The prevalence of
vein diseases is high in population above 60 years at 26%, owing to the factors
such as increasing age and development of conditions like hypertension and
venous thrombosis. The incidence is lowest in the age group of 0 to 17 at 17%
and is majorly due to the risk factors such as genetics, obesity, and
lifestyle-related disorders affecting the arteries and veins.
Increasing technological
advancements due to continuous R&D activities are anticipated to drive the
market for varicose vein treatment devices. Many ongoing clinical trials
conducted by the key market players study the use of novel systems over
traditional treatment methods to gain a competitive edge over the existing
devices. This increases competition in the market enhancing the quality of
products introduced in the market. For instance, in June 2019, the Lake
Washington Vascular Centre conducted a study based on patients with symptomatic
varicose veins treated with Venaseal and Endovenous Thermal Ablation.
The total
expenditure of Americans on combined surgical and nonsurgical cosmetic
procedures was USD 13.5 billion in 2015. The percentage of nonsurgical
procedures has grown by 44% since 2011 and accounted for 42% of the total
expenditure done on cosmetic procedures. These statistics highlight that the
market for varicose vein treatment devices is attractive for cosmetics
purposes.
List of Key
Players in U.S. Varicose Vein Treatment Devices Market
- Medtronic
- AngioDynamics
- Candela Corporation
- Lumenis Be Ltd.
- biolitec Holding GmbH & Co KG
- Eufoton s.r.l.
- Energist
- Quanta System
Related Press Release@ U.S. Varicose Vein Treatment Devices Market Report
U.S. Varicose Vein
Treatment Devices Market Report Highlights
- Based on type, sclerotherapy accounted for the
largest market share in 2023
- Medicare offers insurance for sclerotherapy
procedures for varicose veins, resulting in its high adoption by the
healthcare providers and patients
- In February 2015, Medtronic (then Covidien) received
a pre-market approval from the U.S. Food and Drug Administration (FDA) for
their new product, VenaSeal closure system-a minimally invasive and uses a
medical adhesive to close the damaged vein in patients with vein diseases
U.S. Varicose Vein Treatment
Devices Market Report Scope
|
Report Attribute |
Details |
|
Market
size value in 2024 |
USD 576.0
million |
|
Revenue
Forecast in 2030 |
USD 795.1
million |
|
Growth
Rate |
CAGR of
5.5% from 2024 to 2030 |
|
Actual
data |
2018 -
2023 |
|
Forecast period |
2024 - 2030 |
U.S. Varicose Vein
Treatment Devices Market Segmentation
Grand View
Research has segmented the U.S. varicose vein treatment devices market based on
type:
U.S. Varicose Vein
Treatment Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
- Endovenous Ablation
- Endovenous Laser Therapy
- Radiofrequency Ablation
- Sclerotherapy
- Surgical Ligation/Stripping
Explore Horizon, the world's most expansive market
research database
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment